Intense End-of-Life Care Found to Be Less Likely for VA Patients

Share this content:
Intense End-of-Life Care Found to Be Less Likely for VA Patients
Intense End-of-Life Care Found to Be Less Likely for VA Patients

TUESDAY, Jan. 9, 2018 (HealthDay News) -- Higher-intensity end-of-life care may be driven by financial incentives present in fee-for-service Medicare but not in the Veteran Affairs (VA) integrated system, according to a report published in the January issue of Health Affairs.

Risha Gidwani-Marszowski, Dr. P.H., from the Veterans Affairs Palo Alto Health Care System in Menlo Park, Calif., and colleagues used indicators of overly intensive end-of-life care to compare the quality of care provided to veterans dying of cancer through the VA system and fee-for-service Medicare in fiscal years 2010 to 2014.

The researchers found that Medicare-reliant veterans were significantly more likely to receive high-intensity care, in the form of chemotherapy, hospital stays, admission to the intensive care unit, more days spent in the hospital, and death in the hospital. However, compared to VA-reliant patients, Medicare-reliant veterans were significantly less likely to have multiple emergency department visits. The investigators suggested that financial incentives may drive higher-intensity end-of-life care in fee-for-service Medicare but not in the VA integrated system.

"After adjusting for a variety of covariates shown to influence selection into the VA versus Medicare, we found veterans with solid tumors treated under fee-for-service Medicare were more likely to get unduly intensive health care at the end of life compared to those treated by the VA," the authors write. "To avoid putting VA-reliant veterans at risk of receiving lower-quality care, VA care-purchasing programs should develop coordination and quality monitoring programs to guard against overly intensive end-of-life care."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »